Refurbished Medical Equipment Market - Global Outlook & Forecast 2022-2027

Refurbished Medical Equipment Market - Global Outlook & Forecast 2022-2027

The global refurbished medical equipment market is expected to grow at a CAGR of 11.76% during 2022-2027.

MARKET INSIGHTS

  • The global market is growing due to the increasing number of healthcare settings and increased access to healthcare services. The industry is growing due to the high prevalence of several acute and chronic diseases across the globe.
  • Refurbishment is the systematic process of making used equipment equal to or better than new. Refurbishment is rebuilding or updating with all new materials, components, or parts to restore their original (or better) working condition and appearance. The global refurbished medical equipment market grew significantly during the pre-pandemic times. However, outbreaks of diseases like bird flu, COVID-19, and Monkeypox create a massive demand for used medical equipment.
  • Small & medium-sized hospitals, typically doctor-owned and with less than 100 beds, often cannot afford to buy new high-end equipment. These facilities prefer refurbished equipment of reputed brands that will cost less but perform well for a few years without complaints. These could be young doctors who become self-employed after using such devices in large hospitals. They may be familiar with the equipment models, but they are short on a budget in the early stages of the business. Also, tier 3 cities may have enough patients without enough ability to pay. Such locations cannot provide sufficient return on investment (ROI) for new equipment. Nearly one-third of the medical equipment industry in developing countries is part of the refurbished medical equipment market.
  • Besides important environmental benefits, refurbishing provides sustainable economic benefits by creating business and employment in the refurbished medical equipment market. Even existing equipment owners may consider refurbishing their machines rather than disposing of old ones and buying new ones if their users are comfortable using the specific model. A refurbished asset can be re-capitalized on a depreciation schedule at half the value of new equipment. Refurbishment typically costs about half as much as buying a new one and can bring a machine back to like-new. In addition to the initial cost savings, refurbishment increases resale value and can provide tax benefits to a business, depending on how it’s structured.
  • Apart from cost savings, user comfort with the machines they’ve been using is a bonus. The global refurbished medical equipment market eliminates the annoying problems faced in using a worn-down machine and avoids the learning curve associated with new equipment. Users often grow fond of their devices and love to see their trusted old machines returned to life in better shape than before. The refurbishment also sometimes allows upgrading to the newest available technology.
MARKET TRENDS & OPPORTUNITIES

Increasing Demand for Medical Equipment in Developing Countries
  • The dearth of access to medical equipment in developing countries has attracted global interest in the refurbished medical equipment market for disease diagnosis. Healthcare systems in low-and middle-income countries often have limited access to medical equipment that appears to be in routine use. Implementing medical equipment refurbishment in a developing country would provide employment, increase the knowledge of medical technology among the people, and thus, provide a sustainable supply of skilled personnel for the healthcare industry.
High Capital and Procurement Costs of Medical Equipment
  • Medical equipment typically consists of complex machines that are expensive to purchase and operate and require significant maintenance. Smaller clinics and local medical centers may not be inclined to spend many resources purchasing new equipment that can easily deplete their entire annual budget for just a few devices. Purchasing refurbished medical equipment allows healthcare providers to maximize their budget while providing quality treatment options to each patient. By investing in refurbished equipment, hospitals and clinics can free up much-needed funds for other uses, such as staff, disposables, and medicines, further contributing to the growth of the refurbished medical equipment market.
Growing Preference for Eco-friendly Products
  • The environmental benefits of refurbished medical equipment are also worth touting. By extending the useful life of medical equipment from 5–7 to 10–14 years or even more, refurbishment is a form of reuse and waste prevention, contributing to an environmental economy. Refurbishment saves energy, and the materials are used to produce new equipment. Refurbishing medical equipment and extending its service life maximizes the return on the initial investment of energy and materials. Approximately 90% of the material for a system undergoing refurbishment can be reused; only 10% of the material must be recycled, which is done using environmentally friendly processes.
Hospital Budget Cuts
  • Preparing the hospital's capital budget is an interesting time because it often puts its executives at odds. There are two crucial points where refurbished medical equipment options can assist in this process. The first: relying on refurbished equipment in the development of capital budgets, as pricing options for refurbished equipment early in the process allow to push the price further while allowing for significant upgrades. Second, refurbished equipment can fill the capital budget gap with low-cost options for equipment.
  • In the UK, hospitals are struggling to afford the most advanced scanners and surgical equipment to treat patients who have cancer and other diseases because of multibillion-pound cuts to the NHS’s capital budget. In such cases, the refurbished medical equipment market becomes an ideal choice for hospitals to get the requirements at affordable prices.
Increasing Number of Diagnostic Centers & Hospitals
  • Diagnostic players are entering into outsourcing contracts with hospitals, whereby they would handle the entire diagnostic operations for them. Newly started small hospitals, diagnostic centers, and clinics have a financial burden and cannot dedicate to the new equipment. A few types of medical equipment could easily take up an entire annual budget for a small medical facility. Purchasing refurbished medical equipment is a viable solution contributing to the refurbished medical equipment market. The refurbished medical equipment is upgraded to current standards, ensuring updated equipment for a reasonable price.
Large Inventory of Used or Old Medical Devices
  • Medical equipment inventory is an accepted cost of doing business for manufacturers and is often the most significant cost category. Since medical equipment is typically a high-value product, any efficiencies or cost reductions can quickly contribute to the bottom line. Older equipment does not last forever, and this equipment eventually will need to be replaced and refurbished. It is expected that many facilities will be eager to replace their older systems with the resolution of global supply chain problems. These factors contribute to the rising sales of medical devices, which reflects a large inventory of used medical equipment in the refurbished medical equipment market.
SEGMENTATION INSIGHTS

PRODUCT TYPE INSIGHTS

The global refurbished medical equipment market by product type is segmented into medical imaging, IVD & laboratories, OR, surgical & therapeutic, patient monitoring, cardiology, dental, and others. In 2021, the medical imaging segment dominated the market, accounting for 25.58%. The use of medical diagnostic imaging equipment can resolve between 70 – 80% of diagnostic problems, but nearly 2/3 of the world’s population has no access to diagnostic radiology. Refurbished X-ray machines, ultrasound systems, MRI machines, CT scanners, and nuclear medicine systems (PET, SPECT, and PET/CT) allow healthcare facilities to provide patients with life-saving medical diagnostic imaging services.

The IVD & laboratories equipment segment will likely witness the highest CAGR of 13.14%. Further, the medical imaging equipment segment will account for the highest incremental growth of USD 3.10 billion over the forecast period.

Segmentation by Product Type
  • Medical Imaging Equipment
  • IVD & Laboratories Equipment
  • OR (Operating Room), Surgical and
Therapeutic Equipment
  • Patient Monitoring Equipment
  • Cardiology Equipment
  • Dental Equipment
  • Others
APPLICATIONS INSIGHTS

Diagnosis & monitoring and treatment & surgical interventions are the key segments in the global refurbished medical equipment market by application. In 2021, the diagnosis & monitoring segment dominated the market with a share of 69.46%, followed by treatment & surgical interventions. Medical equipment is extensively utilized for patients’ diagnosis and treatment. Diagnostic and monitoring applications comprise Cardiology, Urology, Neurology, Orthopedics, Physiology, Emergency Medicine, Oncology, Obstetrics/Gynecology (OB/GYN), and others.

Arizton predicts that the treatment & surgical interventions segment will likely witness the highest CAGR of 12.40%. The diagnosis & monitoring segment will account for the highest incremental growth of USD 9.73 billion over the forecast period.

Segmentation Application
  • Diagnosis & Monitoring
  • Treatment & Surgical Interventions
END-USER INSIGHTS

The global refurbished medical equipment market is segmented into hospitals, radiology/medical imaging centers, physicians' offices & dental clinics, clinical & research laboratories, and others by end-user. In 2021, the hospital segment accounted for 37.97% dominating the industry. Arizton predicts that the clinical & research laboratories segment will likely witness the highest CAGR of 12.18%.

The hospital's segment will account for the highest incremental growth of USD 5.24 billion over the forecast period. Hospitals utilize more medical equipment than any other healthcare setting. Diagnostics are the primary screening method in hospitals, which are the first point of contact for any infection and disease. The rising number of people with various infectious diseases encourages physicians in hospitals to use diagnostic imaging equipment, thereby increasing their demand.

Segmentation by End-users
  • Hospitals
  • Radiology/Medical Imaging Centers
  • Clinics, Physician offices & Dental Clinics
  • Clinical & Research Laboratories
  • Others
GEOGRAPHICAL ANALYSIS

The refurbished medical equipment market has a high potential due to low production and material costs, contribution to containing hospital costs, and high growth potential. North America and Europe are the matured market for refurbished medical equipment. In 2021, North America dominated the global refurbished medical equipment market with a share of 28.24%, followed by Europe, APAC, Latin America, and the Middle East & Africa. Arizton predicts that the APAC segment will likely witness the highest CAGR of 14.45% and the highest incremental growth of USD 4.84 billion over the forecast period. Factors associated with the market growth in the region include constant public and private funding, advancements in diagnostic imaging models, and growing medical awareness.

North American refurbished medical equipment market was valued at USD 4.30 billion in 2021.

The North American region is dominating the global refurbished medical equipment market with the aging population, the prevalence of chronic diseases, growing healthcare expenditure, the need for advanced imaging techniques, the presence of well-established players, and a significant shift towards digital medical equipment. Further, the US accounted for 91.21% of the North American refurbished medical equipment market share. One of the major factors driving the demand for refurbished medical equipment in the US is the increasing diseased population, the increasing access to insurance, and the faster adoption of advanced healthcare instruments for treatments.

Segmentation by Geography
  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • APAC
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Turkey
  • UAE
VENDOR LANDSCAPE

The global refurbished medical equipment market is exceptionally active, with fewer global, regional, and local players offering a wide range of medical equipment. The industry is less competitive, as the key players have gained significant refurbished medical equipment market share compared to other prominent players. The market provides the avenue for cheaper access to healthcare delivery and reduces costs in developing countries where these equipment are purchased for use.

The three major manufacturers in the refurbished medical equipment market, GE Healthcare, Koninklijke Philips, and Siemens Healthineers, have implemented the refurbished process and sold their refurbished medical equipment under distinct brand names. In 2021, North America was the largest regional refurbished medical equipment market. It was primarily attributed to the presence of many private healthcare facilities, the increasing aging population, the high prevalence of various diseases, ongoing reimbursement cuts, and regulatory scenarios for the sale and use of refurbished medical equipment in the US.

Key Vendors
  • General Electric Company
  • Koninklijke Philips
  • Siemens Healthineers
Other Prominent Vendors
  • Amber Diagnostics
  • Apt Medical Systems
  • Avante Health Solutions
  • Block Imaging
  • EverX
  • Future Health Concepts
  • Medirays
  • Meridian Medical
  • PACIFIC HEALTHCARE IMAGING
  • Radiology Oncology System
  • Soma Tech Intl
  • US Med-Equip’s
  • US Medical Systems
  • Venture Medical ReQuip
KEY QUESTIONS ANSWERED

1. What is the expected refurbished medical equipment market size by 2027?

2. What is the growth rate of the global refurbished medical equipment market?

3. Who are the key companies in the global refurbished medical equipment market?

4. What are the latest refurbished medical equipment market trends globally?

5. Which region holds the largest refurbished medical equipment market share globally?


1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET SEGMENTATION BY THERAPY AREA
4.3.2 MARKET SEGMENTATION BY ORIGIN
4.3.3 MARKET SEGMENTATION BY PRODUCT
4.3.4 MARKET SEGMENTATION BY FUNCTION
4.3.5 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 MARKET AT A GLANCE
7 INTRODUCTION
7.1 BACKGROUND
7.2 IMPACT OF COVID-19 ON GLOBAL SUPPLY CHAIN
8 PREMIUM INSIGHTS
9 MARKET OPPORTUNITIES & TRENDS
9.1 GROWING DEMAND FOR CLINICAL TRIALS LOGISTICS
9.2 DIGITAL TRANSFORMATIONS IN PHARMA LOGISTICS
9.3 INCREASING DEMAND FOR CELL & GENE THERAPY LOGISTICS
10 MARKET GROWTH ENABLERS
10.1 INCREASING DEMAND FOR TEMPERATURE-SENSITIVE MEDICINES
10.2 GROWING DEMAND FOR OCEAN FREIGHT SERVICE
10.3 INCREASING DEMAND FOR GENERICS AND BIOSIMILARS
11 MARKET RESTRAINTS
11.1 LACK OF COMPLIANCE AND CHANGING REGULATIONS
11.2 IMPACT OF COVID-19 PANDEMIC
11.3 GEOPOLITICAL RISKS & CHANGES IN INTERNATIONAL TRADE POLICIES AND RELATIONS
12 MARKET LANDSCAPE
12.1 MARKET OVERVIEW
12.2 MARKET SIZE & FORECAST
12.2.1 INSIGHTS BY THERAPY AREA
12.2.2 INSIGHTS BY ORIGIN
12.2.3 INSIGHTS BY PRODUCT
12.2.4 INSIGHTS BY FUNCTION
12.2.5 INSIGHTS BY GEOGRAPHY
12.3 FIVE FORCES ANALYSIS
12.3.1 THREAT OF NEW ENTRANTS
12.3.2 BARGAINING POWER OF SUPPLIERS
12.3.3 BARGAINING POWER OF BUYERS
12.3.4 THREAT OF SUBSTITUTES
12.3.5 COMPETITIVE RIVALRY
13 THERAPY AREA
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 COMMUNICABLE DISEASES
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.3.3 MARKET BY GEOGRAPHY
13.4 ONCOLOGY
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.4.3 MARKET BY GEOGRAPHY
13.5 DIABETES
13.5.1 MARKET OVERVIEW
13.5.2 MARKET SIZE & FORECAST
13.5.3 MARKET BY GEOGRAPHY
13.6 CARDIOVASCULAR DISEASES
13.6.1 MARKET OVERVIEW
13.6.2 MARKET SIZE & FORECAST
13.6.3 MARKET BY GEOGRAPHY
13.7 AUTOIMMUNE DISEASES
13.7.1 MARKET OVERVIEW
13.7.2 MARKET SIZE & FORECAST
13.7.3 MARKET BY GEOGRAPHY
13.8 NEUROLOGICAL DISORDERS
13.8.1 MARKET OVERVIEW
13.8.2 MARKET SIZE & FORECAST
13.8.3 MARKET BY GEOGRAPHY
13.9 PAIN MANAGEMENT
13.9.1 MARKET OVERVIEW
13.9.2 MARKET SIZE & FORECAST
13.9.3 MARKET BY GEOGRAPHY
13.10 RESPIRATORY DISEASES
13.10.1 MARKET OVERVIEW
13.10.2 MARKET SIZE & FORECAST
13.10.3 MARKET BY GEOGRAPHY
13.11 OTHERS
13.11.1 MARKET OVERVIEW
13.11.2 MARKET SIZE & FORECAST
13.11.3 MARKET BY GEOGRAPHY
14 ORIGIN
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 BRANDED DRUGS
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.3.3 MARKET BY GEOGRAPHY
14.4 GENERIC DRUGS
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.4.3 MARKET BY GEOGRAPHY
14.5 OTC
14.5.1 MARKET OVERVIEW
14.5.2 MARKET SIZE & FORECAST
14.5.3 MARKET BY GEOGRAPHY
15 PRODUCT
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 SMALL MOLECULE DRUGS
15.3.1 MARKET OVERVIEW
15.3.2 MARKET SIZE & FORECAST
15.3.3 MARKET BY GEOGRAPHY
15.4 BIOLOGICS
15.4.1 MARKET OVERVIEW
15.4.2 MARKET SIZE & FORECAST
15.4.3 MARKET BY GEOGRAPHY
15.5 MONOCLONAL ANTIBODIES
15.5.1 MARKET OVERVIEW
15.5.2 MARKET SIZE & FORECAST
15.6 VACCINES
15.6.1 MARKET OVERVIEW
15.6.2 MARKET SIZE & FORECAST
15.7 OTHERS
15.7.1 MARKET OVERVIEW
15.7.2 MARKET SIZE & FORECAST
16 FUNCTION
16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 MARKET OVERVIEW
16.3 TRANSPORTATION
16.3.1 MARKET OVERVIEW
16.3.2 MARKET SIZE & FORECAST
16.3.3 MARKET BY GEOGRAPHY
16.4 ROAD
16.4.1 MARKET OVERVIEW
16.4.2 MARKET SIZE & FORECAST
16.5 WATER
16.5.1 MARKET OVERVIEW
16.5.2 MARKET SIZE & FORECAST
16.6 AIR
16.6.1 MARKET OVERVIEW
16.6.2 MARKET SIZE & FORECAST
16.7 WAREHOUSING
16.7.1 MARKET OVERVIEW
16.7.2 MARKET SIZE & FORECAST
16.7.3 MARKET BY GEOGRAPHY
16.8 OTHERS
16.8.1 MARKET OVERVIEW
16.8.2 MARKET SIZE & FORECAST
16.8.3 MARKET BY GEOGRAPHY
17 GEOGRAPHY
17.1 MARKET SNAPSHOT & GROWTH ENGINE
17.2 GEOGRAPHIC OVERVIEW
18 NORTH AMERICA
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.3 NORTH AMERICA BY THERAPY AREA
18.4 NORTH AMERICA BY ORIGIN
18.5 NORTH AMERICA BY PRODUCT
18.6 NORTH AMERICA BY FUNCTION
18.7 KEY COUNTRIES
18.7.1 US: MARKET SIZE & FORECAST
18.7.2 CANADA: MARKET SIZE & FORECAST
19 EUROPE
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.3 EUROPE BY THERAPY AREA
19.4 EUROPE BY ORIGIN
19.5 EUROPE BY PRODUCT
19.6 EUROPE BY FUNCTION
19.7 KEY COUNTRIES
19.7.1 GERMANY: MARKET SIZE & FORECAST
19.7.2 FRANCE: MARKET SIZE & FORECAST
19.7.3 UK: MARKET SIZE & FORECAST
19.7.4 ITALY: MARKET SIZE & FORECAST
19.7.5 SPAIN: MARKET SIZE & FORECAST
20 APAC
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.3 APAC BY THERAPY AREA
20.4 APAC BY ORIGIN
20.5 APAC BY PRODUCT
20.6 APAC BY FUNCTION
20.7 KEY COUNTRIES
20.7.1 CHINA: MARKET SIZE & FORECAST
20.7.2 JAPAN: MARKET SIZE & FORECAST
20.7.3 INDIA: MARKET SIZE & FORECAST
20.7.4 SOUTH KOREA: MARKET SIZE & FORECAST
20.7.5 AUSTRALIA: MARKET SIZE & FORECAST
21 LATIN AMERICA
21.1 MARKET OVERVIEW
21.2 MARKET SIZE & FORECAST
21.3 LATIN AMERICA BY THERAPY AREA
21.4 LATIN AMERICA BY ORIGIN
21.5 LATIN AMERICA BY PRODUCT
21.6 LATIN AMERICA BY FUNCTION
21.7 KEY COUNTRIES
21.7.1 BRAZIL: MARKET SIZE & FORECAST
21.7.2 MEXICO: MARKET SIZE & FORECAST
21.7.3 ARGENTINA: MARKET SIZE & FORECAST
22 MIDDLE EAST & AFRICA
22.1 MARKET OVERVIEW
22.2 MARKET SIZE & FORECAST
22.3 MIDDLE EAST & AFRICA BY THERAPY AREA
22.4 MIDDLE EAST & AFRICA BY ORIGIN
22.5 MIDDLE EAST & AFRICA BY PRODUCT
22.6 MIDDLE EAST & AFRICA BY FUNCTION
22.7 KEY COUNTRIES
22.7.1 TURKEY: MARKET SIZE & FORECAST
22.7.2 SAUDI ARABIA: MARKET SIZE & FORECAST
22.7.3 SOUTH AFRICA: MARKET SIZE & FORECAST
23 COMPETITIVE LANDSCAPE
23.1 COMPETITION OVERVIEW
23.1.1 AMERISOURCEBERGEN
23.1.2 DB GROUP
23.1.3 DEUTSCHE POST DHL
23.1.4 CEVA LOGISTICS
23.1.5 UNITED PARCEL SERVICE
23.1.6 FEDEX
23.1.7 KUEHNE+NAGEL
24 KEY COMPANY PROFILES
24.1 AMERISOURCEBERGEN
24.1.1 BUSINESS OVERVIEW
24.1.2 SERVICE OFFERINGS
24.1.3 KEY STRATEGIES
24.1.4 KEY STRENGTHS
24.1.5 KEY OPPORTUNITIES
24.2 CEVA LOGISTICS
24.2.1 BUSINESS OVERVIEW
24.2.2 SERVICE OFFERINGS
24.2.3 KEY STRATEGIES
24.2.4 KEY STRENGTHS
24.2.5 KEY OPPORTUNITIES
24.3 DB GROUP
24.3.1 BUSINESS OVERVIEW
24.3.2 SERVICE OFFERINGS
24.3.3 KEY STRATEGIES
24.3.4 KEY STRENGTHS
24.3.5 KEY OPPORTUNITIES
24.4 DEUTSCHE POST DHL
24.4.1 BUSINESS OVERVIEW
24.4.2 SERVICE OFFERINGS
24.4.3 KEY STRATEGIES
24.4.4 KEY STRENGTHS
24.4.5 KEY OPPORTUNITIES
24.5 FEDEX
24.5.1 BUSINESS OVERVIEW
24.5.2 SERVICE OFFERINGS
24.5.3 KEY STRATEGIES
24.5.4 KEY STRENGTHS
24.5.5 KEY OPPORTUNITIES
24.6 KUEHNE + NAGEL
24.6.1 BUSINESS OVERVIEW
24.6.2 SERVICE OFFERINGS
24.6.3 KEY STRATEGIES
24.6.4 KEY STRENGTHS
24.6.5 KEY OPPORTUNITIES
24.7 UNITED PARCEL SERVICE
24.7.1 BUSINESS OVERVIEW
24.7.2 SERVICE OFFERINGS
24.7.3 KEY STRATEGIES
24.7.4 KEY STRENGTHS
24.7.5 KEY OPPORTUNITIES
25 OTHER PROMINENT VENDORS
25.1 ABS LOGISTICS
25.1.1 BUSINESS OVERVIEW
25.1.2 SERVICE OFFERINGS
25.2 AWL INDIA
25.2.1 BUSINESS OVERVIEW
25.2.2 SERVICE OFFERINGS
25.3 ALLOGA
25.3.1 BUSINESS OVERVIEW
25.3.2 SERVICE OFFERINGS
25.4 BOLLORÉ LOGISTICS
25.4.1 BUSINESS OVERVIEW
25.4.2 SERVICE OFFERINGS
25.5 CARDINAL HEALTH
25.5.1 BUSINESS OVERVIEW
25.5.2 SERVICE OFFERINGS
25.6 C.H. ROBINSON
25.6.1 BUSINESS OVERVIEW
25.6.2 SERVICE OFFERINGS
25.7 COLD CHAIN TECHNOLOGIES
25.7.1 BUSINESS OVERVIEW
25.7.2 SERVICE OFFERINGS
25.8 CRYOPDP
25.8.1 BUSINESS OVERVIEW
25.8.2 SERVICE OFFERINGS
25.9 DPD
25.9.1 BUSINESS OVERVIEW
25.9.2 SERVICE OFFERINGS
25.10 DSV
25.10.1 BUSINESS OVERVIEW
25.10.2 SERVICE OFFERINGS
25.11 FARMASOFT
25.11.1 BUSINESS OVERVIEW
25.11.2 SERVICE OFFERINGS
25.12 JEENA & COMPANY
25.12.1 BUSINESS OVERVIEW
25.12.2 SERVICE OFFERINGS
25.13 LUFTHANSA CARGO
25.13.1 BUSINESS OVERVIEW
25.13.2 SERVICE OFFERINGS
25.14 A.P. MOLLER - MAERSK
25.14.1 BUSINESS OVERVIEW
25.14.2 SERVICE OFFERINGS
25.15 MEDLINE
25.15.1 BUSINESS OVERVIEW
25.15.2 SERVICE OFFERINGS
25.16 NIPPON EXPRESS
25.16.1 BUSINESS OVERVIEW
25.16.2 SERVICE OFFERINGS
25.17 NOATUM LOGISTICS
25.17.1 BUSINESS OVERVIEW
25.17.2 SERVICE OFFERINGS
25.18 OWENS & MINOR
25.18.1 BUSINESS OVERVIEW
25.18.2 SERVICE OFFERINGS
25.19 OXIMIO
25.19.1 BUSINESS OVERVIEW
25.19.2 SERVICE OFFERINGS
25.20 PHARMA LOGISTICS
25.20.1 BUSINESS OVERVIEW
25.20.2 SERVICE OFFERINGS
25.21 PHOENIX GROUP
25.21.1 BUSINESS OVERVIEW
25.21.2 SERVICE OFFERINGS
25.22 PAREXEL INTERNATIONAL
25.22.1 BUSINESS OVERVIEW
25.22.2 SERVICE OFFERINGS
25.23 SEKO LOGISTICS
25.23.1 BUSINESS OVERVIEW
25.23.2 SERVICE OFFERINGS
25.24 SINGAPORE POST
25.24.1 BUSINESS OVERVIEW
25.24.2 SERVICE OFFERINGS
25.25 SINOTRANS
25.25.1 BUSINESS OVERVIEW
25.25.2 SERVICE OFFERINGS
25.26 XPO LOGISTICS
25.26.1 BUSINESS OVERVIEW
25.26.2 SERVICE OFFERINGS
25.27 YOURWAY
25.27.1 BUSINESS OVERVIEW
25.27.2 SERVICE OFFERINGS
25.28 YUSEN LOGISTICS
25.28.1 BUSINESS OVERVIEW
25.28.2 SERVICE OFFERINGS
26 REPORT SUMMARY
26.1 KEY TAKEAWAYS
26.2 STRATEGIC RECOMMENDATIONS
27 QUANTITATIVE SUMMARY
27.1 MARKET BY GEOGRAPHY
27.2 MARKET BY THERAPY AREA
27.3 MARKET BY ORIGIN
27.4 MARKET BY PRODUCT
27.5 MARKET BY FUNCTION
27.6 NORTH AMERICA BY THERAPY AREA
27.7 NORTH AMERICA BY ORIGIN
27.8 NORTH AMERICA BY PRODUCT
27.9 NORTH AMERICA BY FUNCTION
27.10 EUROPE BY THERAPY AREA
27.11 EUROPE BY ORIGIN
27.12 EUROPE BY PRODUCT
27.13 EUROPE BY FUNCTION
27.14 APAC BY THERAPY AREA
27.15 APAC BY ORIGIN
27.16 APAC BY PRODUCT
27.17 APAC BY FUNCTION
27.18 LATIN AMERICA BY THERAPY AREA
27.19 LATIN AMERICA BY ORIGIN
27.20 LATIN AMERICA BY PRODUCT
27.21 LATIN AMERICA BY FUNCTION
27.22 MIDDLE EAST & AFRICA AMERICA BY THERAPY AREA
27.23 MIDDLE EAST & AFRICA BY ORIGIN
27.24 MIDDLE EAST & AFRICA BY PRODUCT
27.25 MIDDLE EAST & AFRICA BY FUNCTION
28 APPENDIX
28.1 ABBREVIATIONS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings